Mr. Chair, it's not on the agenda, and I know we're only looking at the election officers, but we have a bit of a dilemma with the CETA. The next-to-final round of negotiations could be in July.
The European Parliament demands that negotiators keep Parliament informed. That's not the case here...and again, the consent of Parliament. I do think that we may need to, even as a committee....
Now, certainly four opposition members could write a letter to the chair and ask for a meeting, but I think we ought to seriously consider a meeting to find out where these negotiations are really at on CETA sometime this summer.
There are a lot of implications here. There's the additional pharmaceutical costs to Canada if we go with the European pharmaceutical approach; $2.8 billion it would cost our health care system or insurance companies or whatever. There is the issue of supply management. There is the issue of procurement.
Those are the pretty serious issues that I see, and I think the committee has a responsibility to delve into those issues and try to find out what they are. We need to know what's on the table.
I think July 11 to 15 is the last round in Brussels, Gerald, is it not? Or is the next round in Brussels--
